Accessibility Menu
 
Jack Nathan Medical logo

Jack Nathan Medical

(OTC) JNHMF

Current Price$0.00
Market Cap$33,100
Since IPO (2020)-100%
5 Year-100%
1 Year-97%
1 Month-91%

Jack Nathan Medical Financials at a Glance

Market Cap

$33,100

Revenue (TTM)

$3.45M

Net Income (TTM)

$9.37M

EPS (TTM)

$0.00

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

3.42 (High)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.03

JNHMF News

No articles available.

JNHMF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jack Nathan Medical

Industry

Healthcare Providers and Services

CEO

Michael Marchelletta

Headquarters

Woodbridge, ON L4H 0R6, CA

JNHMF Financials

Key Financial Metrics (TTM)

Gross Margin

87%

Operating Margin

-41%

Net Income Margin

3%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

6%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$33.10K

Shares Outstanding

41.35M

Volume

1.00K

Short Interest

0.00%

Avg. Volume

131.148

Financials (TTM)

Gross Profit

$7.37M

Operating Income

$2.48M

EBITDA

$1.54M

Operating Cash Flow

$6.36M

Capital Expenditure

$1.18M

Free Cash Flow

$7.54M

Cash & ST Invst.

$2.20M

Total Debt

$243.31K

Jack Nathan Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$227.53K

-95.8%

Gross Profit

$8.57K

-100.2%

Gross Margin

-3.77%

N/A

Market Cap

$33.10K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$42.16K

+98.2%

EBITDA

$460.06K

+67.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$596.33K

+104.9%

Accounts Receivable

$246.17K

-86.0%

Inventory

$0.00

N/A

Long Term Debt

$163.49K

-98.5%

Short Term Debt

$42.57K

-98.1%

Return on Assets

6.01%

N/A

Return on Invested Capital

-2.12%

N/A

Free Cash Flow

$44.44K

+95.0%

Operating Cash Flow

$44.44K

+94.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BRAXFBraxia Scientific Corp.
$0.00+0.00%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%
PXYNPraxsyn Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%

Questions About JNHMF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.